In addition to the analysis of epithelial and mixed CTCs, we utilized the CytoSorter® CSV mesenchymal CTC kit (Hangzhou Watson Biotech, Hangzhou, China) to identify and enrich CTCs expressing cell-surface vimentin, and assessed the clinical significance of their presence in CRC patients in the present study. Here, VIM is linked to colorectal carcinoma.